Consolidated Statements of Cash Flows (USD $)	6 Months Ended
Consolidated Statements of Cash Flows (USD $)	Jun. 30, 2011	Jun. 30, 2010
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (4,243,689)	$ (5,920,631)
Adjustments to reconcile net loss to net cash used in operating activities:
Bad debt expense		5,609
Amortization of prepaid consulting fee	733,000	71,339
Amortization of debt issuance costs	86,729	74,513
Depreciation and amortization expense	44,955	56,667
Issuance of common stock pursuant to separation agreement		105,000
Compensation expense associated with stock options and restricted stock to employees	252,416	1,084,613
Stock options issued to non-employees for services		3,318
Gain on net change in fair value of derivative liabilities	(206,110)	4,996
Loss on conversion of debt	403,163
Changes in operating assets and liabilities:
Accounts receivable		58,291
Other receivables	9,095
Prepaid expenses and other current assets	51,451	107,066
Other assets		(40,739)
Accounts payable and accrued expenses	467,559	1,591,093
Deferred rent	(42,591)	(40,272)
Net cash used in operating activities	(1,250,882)	(2,328,924)
CASH FLOWS FROM INVESTING ACTIVITIES:
Net increase in restricted cash	(4)	(14,702)
Purchases of property and equipment		(52,048)
Capitalized patent costs		(13,282)
Net cash used in investing activities	(4)	(80,042)
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments for license agreement payable		(120,000)
Proceeds from issuance of common stock, net		1,543,350
Proceeds from the issuance of convertible notes	1,262,500	700,000
Debt issuance costs	(53,750)	(20,000)
Repayment of convertible notes	(100,000)
Net cash provided by financing activities	1,108,750	2,103,350
Decrease in cash and cash equivalents	(142,136)	(305,616)
Cash and cash equivalents - beginning of period	149,909	567,647
Cash and cash equivalents - end of period	7,773	262,031
Supplemental Disclosure of Non-Cash Operating and Financing Activities
Accrued dividends on preferred stock	129,147	274,479
Anti-dilution obligation associated with issuance of common stock		40,000
Issuance of warrants for debt issuance costs	19,223
Issuance of warrants with convertible debt	157,777
Embedded conversion feature on convertible debt	57,480
Debt discount as a result of beneficial conversion feature associated with convertible debt modification	341,965
Conversion of debt to common stock	4
Discount on convertible notes associated with detachable warrants		149,949
Issuance of warrants to non-employees for deferred financing costs		38,165
Accrued preferred stock dividends converted into shares of common stock	1,212,813	488,334
Deferred financing costs included in accrued expenses		50,000
License Agreement
Changes in operating assets and liabilities:
Amortization	308,222	368,501
Loss on extinguishment / settlement of debt		(154,000)
Supplemental Disclosure of Non-Cash Operating and Financing Activities
Common stock issued		726,000
Patents
Changes in operating assets and liabilities:
Amortization	19,540
Write-off of capitalized costs	271,728
Convertible Notes Payable \| Premium
Changes in operating assets and liabilities:
Amortization of debt discount/premium	(1,870)
Convertible Notes Payable \| Discount
Changes in operating assets and liabilities:
Amortization of debt discount/premium	148,665	103,298
Notes Payable, Other Payables
Changes in operating assets and liabilities:
Amortization of debt discount/premium	8,269
Construction in Progress
Changes in operating assets and liabilities:
Write-off of capitalized costs	128,095
Convertible Debt
Changes in operating assets and liabilities:
Loss on extinguishment / settlement of debt	163,305
Trade Payables
Changes in operating assets and liabilities:
Loss on extinguishment / settlement of debt	(19,983)
Accounts Payable and Accrued Expenses
Supplemental Disclosure of Non-Cash Operating and Financing Activities
Common stock issued	10,000
Class B common stock warrant liability
Supplemental Disclosure of Non-Cash Operating and Financing Activities
Issuance of promissory note	7,444
Debt Issuance Costs
Supplemental Disclosure of Non-Cash Operating and Financing Activities
Issuance of promissory note	17,500
Settlement of Anti-dilution Obligation
Supplemental Disclosure of Non-Cash Operating and Financing Activities
Common stock issued		58,449
Series A Cumulative Convertible Preferred Stock
Supplemental Disclosure of Non-Cash Operating and Financing Activities
Conversion of preferred stock to common stock		710,970
Series B Cumulative Convertible Preferred Stock
Supplemental Disclosure of Non-Cash Operating and Financing Activities
Conversion of preferred stock to common stock	3,094,872
License Agreement Payable
Changes in operating assets and liabilities:
Amortization of debt discount/premium	167,169	192,414
Loss on extinguishment / settlement of debt		$ (154,000)

New Generation Biofuels Holdings, Inc 10-Q/A